REPL - Replimune Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20183/31/2017
Total Revenue--
Cost of Revenue--
Gross Profit--
Operating Expenses
Research Development11,2495,494
Selling General and Administrative5,7132,711
Non Recurring--
Others--
Total Operating Expenses16,9628,205
Operating Income or Loss-16,962-8,205
Income from Continuing Operations
Total Other Income/Expenses Net-2,740501
Earnings Before Interest and Taxes-16,962-8,205
Interest Expense--
Income Before Tax-19,702-7,704
Income Tax Expense--
Minority Interest--
Net Income From Continuing Ops-19,702-7,704
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-19,702-7,704
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-19,702-7,704